Dr Le (Christy) Ying

Marks ZRC, Campbell NK, Mangan NE, Vandenberg CJ, Gearing LJ, Matthews AY, Gould JA, Tate MD, Wray-McCann G, Ying L, Rosli S, Brockwell N, Parker BS, Lim SS, Bilandzic M, Christie EL, Stephens AN, Geus ED, Wakefield MJ, Ho G, McNally O, Australian Ovarian Cancer Study, McNeish LA, Bowtell DDL, Weerd And, Scott CL, Bourke NM, Hertzog PJ (2023). Interferon-ε is a tumour suppressor and restricts ovarian cancer. Nature. doi: 10.1038/s41586-023-06421-w.

Tran LS, Ying L, D’Costa K, Wray-McCann G, Kerr G, Le L, Allison CC, Ferrand J, Chaudhry H, Emery J, Paoli A De, Colon N, Creed S, Kaparakis-Liaskos M, Como J, Dowling JK, Johanesen PA, Kufer TA, Pedersen JS, Mansell A, Philpott DJ, Elgass KD, Abud HE, Nachbur U, Croker BA, Masters SL, Ferrero RL (2023). NOD1 mediates interleukin-18 processing in epithelial cells responding to Helicobacter pylori infection in mice. Nat Commun. 14(1). 3804.

Ying L, Liu P, Ding Z, Wray‐McCann G, Emery J, Colon N, Le HM, Tran LS, Xu P, Yu L, Philpott DJ, Tu Y, Cheah DM, Cheng CL, Lim ST, Ong CK, Ferrero RL (2023). Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell MALT lymphoma in a mouse model. J Pathol. 259(4):402-414.

Liu C, Deng L, Lin J, Zhang J, Huang S, Zhao J, Jin P, Xu P, Ni P, Xu D, Ying L*, Hu Y (2021). Zinc Finger Protein CTCF Regulates Extracellular Matrix (ECM)-Related Gene Expression Associated With the Wnt Signaling Pathway in Gastric Cancer. Front Oncol. 10: 625633  (*senior author)

Qiao B, Huang J, Mei Z, Lam AK yin, Zhao J, Ying L* (2020). Analysis of Immune Microenvironment by Multiplex Immunohistochemistry Staining in Different Oral Diseases and Oral Squamous Cell Carcinoma. Front Oncol. 10:555757 (*senior author)

Xu P, Yan F, Zhao Y, Chen X, Sun S, Wang Y, Ying L* (2020). Green tea polyphenol EGCG attenuates MDSCs-mediated immunosuppression through canonical and non-canonical pathways in a 4T1 murine breast cancer model. Nutrients. 12(4). 1024 (*senior author)

Wang M, Huang YK, Kong JCH, Sun Y, Tantalo DG, Aw Yeang HX, Ying L, Yan F, Xu D, Halse H, Costanzo ND, Gordon IR, Mitchell C, Mackey LK, Busuttil R, Neeson PJ, Boussioutas A (2020). High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancer. Clin Transl Immunol. 9(5): e1127.

Ying L*, Yan F, Xu D (2020). Cancer patient stratification based on the tumor microenvironment. J Thorac Dis. 12(8):4522-4526 (*senior author)

Ying L, Ferrero RL (2019). Role of NOD1 and ALPK1/TIFA signalling in innate immunity against helicobacter pylori infection. Current Topics in Microbiology and Immunology. 2019. 421:159-177

Ying L, Yan F, Meng Q, Yu L, Yuan X, Gantier MP, Williams BRG, Chan DW, Shi L, Tu Y, Ni P, Wang X, Chen W, Zang X, Xu D, Hu Y (2018). PD-L1 expression is a prognostic factor in subgroups of gastric cancer patients stratified according to their levels of CD8 and FOXP3 immune markers. Oncoimmunology. 7(6):e1433520.

Ying L, Yan F, Williams BR, Xu P, Li X, Zhao Y, Hu Y, Wang Y, Xu D, Dai J (2018). (-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells. Clin Exp Pharmacol Physiol. 45(1):58–67.